COVID-19 and gastrointestinal symptoms

Sumukhi Das

doi:10.4172/2161-069X.1000642

ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Commentary
J Gastrointest Dig Syst 2021, Vol 11(1): 642
DOI: 10.4172/2161-069X.1000642

COVID-19 and gastrointestinal symptoms

Sumukhi Das^*: Banasthali University, Rajasthan, India

^*Corresponding Author : Sumukhi Das, Banasthali University, Rajasthan, India, Email: sumkhids@gmail.com

Abstract

The presence of gastrointestinal symptoms in patients with COVID-19 was related to an additional severe course of health problem and bigger probability of mortality, in an exceedingly prospective study of a population with very little exposure to medicine with adverse GI effects. Infection with SARS-CoV-2 is more and more recognized to cause GI symptoms additionally to the internal and external respiratory symptoms. The prevalence of GI symptoms rumoured in our study could also be a real reflection of the frequency (with COVID-19) as a result of most of those patients weren't hospitalized and weren't on medicine which may be related to GI symptoms.

Keywords: Gastrointestinal symptoms, COVID19, Angiotensin, Serotonin

View PDF Download PDF